Search Results - "Halter, Jörg P"

Inert Gas Washout in Bronchiolitis Obliterans Following Hematopoietic Cell Transplantation by Nyilas, Sylvia, Baumeler, Luzia, Tamm, Michael, Halter, Jörg P., Savic, Spasenija, Korten, Insa, Meyer, Anja, Singer, Florian, Passweg, Jakob R., Latzin, Philipp, Stolz, Daiana

“…Bronchiolitis obliterans syndrome (BOS) is a leading cause of chronic graft-vs-host disease (cGvHD) and is associated with mortality after allogeneic…”
Get full text

Technical comment on: Trottmann M, et al. Real-world expenditures and survival time after CAR-T treatment for large B-cell lymphoma in Switzerland: a retrospective study using insurance claims data by Arber, Caroline, Baerlocher, Gabriela, Chalandon, Yves, Daskalakis, Michael, Duchosal, Michel, Fehr, Martin, Gerull, Sabine, Güngör, Tayfun, Nair, Gayathri, Pabst, Thomas, Passweg, Jakob R, Piccolruaz, Barbara, Renner, Christoph, Ruefer, Axel, Schneidawind, Dominik, Stüssi, Georg, Zeerleder, Sacha, Halter, Jörg P

Get full text

Reduced dose of post-transplantation cyclophosphamide compared to ATG for graft-versus-host disease prophylaxis in recipients of mismatched unrelated donor hematopoietic cell transplantation: a single-center study by Soltermann, Yves, Heim, Dominik, Medinger, Michael, Baldomero, Helen, Halter, Jörg P., Gerull, Sabine, Arranto, Christian, Passweg, Jakob R., Kleber, Martina

“…Post-transplantation cyclophosphamide (PTCy) demonstrated effectiveness to prevent GVHD after haploidentical hematopoietic cell transplantation (HCT). Reducing…”
Get full text

New-onset Post-transplant Diabetes and Therapy in Long-term Survivors After Allogeneic Hematopoietic Stem Cell Transplantation by Dalla Via, Vera, Halter, JÖrg P, Gerull, Sabine, Arranto, Christian, Tichelli, AndrÉ, Heim, Dominik, Passweg, Jakob R, Medinger, Michael, Cesana-Nigro, Nicole

“…Survival after allogeneic hematopoietic stem cell transplantation (allo-HSCT) has increased but so have long-term sequelae. New-onset post-transplant diabetes…”
Get full text

Characterization of engraftment dynamics in myelofibrosis after allogeneic hematopoietic cell transplantation including novel conditioning schemes by Jungius, Sarah, Adam, Franziska C., Grosheintz, Kerstin, Medinger, Michael, Buser, Andreas, Passweg, Jakob R., Halter, Jörg P., Meyer, Sara C.

“…Introduction Myelofibrosis (MF) is a rare hematopoietic stem cell disorder progressing to bone marrow (BM) failure or blast phase. Allogeneic hematopoietic…”
Get full text

Hematopoietic cell transplantation and cellular therapies in Switzerland. Evolution over 25 years. A report from the stem cell transplantation and cellular therapies working groups of the SBST 1997–2021 by Passweg, Jakob R., Baldomero, Helen, Ansari, Marc, Arber, Caroline, Chalandon, Yves, Daskalakis, Michael, Diepold, Miriam, Diesch‐Furlanetto, Tamara, Duchosal, Michel A., Gerull, Sabine, Güngör, Tayfun, Heim, Dominik, Hitz, Felicitas, Holbro, Andreas, Masouridi‐Levrat, Stavroula, Nair, Gayathri, Novak, Urban, Pabst, Thomas, Renner, Christoph, Stussi, Georg, Schneidawind, Dominik, Schanz, Urs, Wannesson, Luciano, Halter, Jörg P.

“…The Swiss Blood Stem Cell Transplantation and Cellular Therapy Group (SBST) leads a mandatory national registry for all hematopoietic stem cell transplants…”
Get full text

Toxicity associated with PD-1 blockade after allogeneic haematopoietic cell transplantation by Ortega Sanchez, Guacimara, Stenner, Frank, Dirnhofer, Stephan, Passweg, Jakob, Gerull, Sabine, Halter, Jörg P, Zippelius, Alfred, Läubli, Heinz

“…Cancer immunotherapy with immune checkpoint inhibitors (ICIs) such as programmed death ligand-1 (PD-L1) blockers offers pronounced clinical benefit with…”
Get full text

Case report: mRNA-1273 COVID-19 vaccine-associated myopericarditis: Successful treatment and re-exposure with colchicine by Valore, Luca, Junker, Till, Heilmann, Eva, Zuern, Christine S, Streif, Matthias, Drexler, Beatrice, Arranto, Christian, Halter, Jörg P, Berger, Christoph T

“…Vaccine-induced myocarditis is a rare complication of messenger RNA (mRNA) COVID-19 vaccines. We report a case of acute myopericarditis in a recipient of…”
Get full text

External Validation of the Revised Pretransplant Assessment of Mortality Score in Allogeneic Hematopoietic Cell Transplantation: A Cohort Study by Fattinger, Nicolas, Roth, Jan A., Baldomero, Helen, Stolz, Daiana, Medinger, Michael, Heim, Dominik, Tamm, Michael, Halter, Jörg P., Passweg, Jakob R., Kleber, Martina

“…Pretransplant risk scores such as the revised Pretransplant Assessment of Mortality (rPAM) score help to predict outcome of patients receiving allogeneic…”
Get full text

Co-Occurring CSF3R W791 Germline and Somatic T618I Driver Mutations Induce Early CNL and Clonal Progression to Mixed Phenotype Acute Leukemia by Adam, Franziska C, Szybinski, Jakub, Halter, Jörg P, Cantoni, Nathan, Wenzel, Friedel, Leonards, Katharina, Brkic, Sime, Passweg, Jakob R, Touw, Ivo, Maxson, Julia E, Meyer, Sara C

“…Chronic neutrophilic leukemia (CNL) relates to mutational CSF3R activation with membrane proximal mutations such as T618I as driver mutations, but the…”
Get full text

Immune cytopenia after allogeneic haematopoietic stem-cell transplantation: challenges, approaches, and future directions by Baur, Katharina, Buser, Andreas S, Infanti, Laura, Halter, Jörg P, Passweg, Jakob R, Holbro, Andreas

“…Immune-mediated cytopenia after allogeneic haematopoietic stem-cell transplantation is rare. The pathophysiology of immune-mediated anaemia, thrombocytopenia,…”
Get full text

Suitability of haematopoietic cell donors: updated consensus recommendations from the WBMT standing committee on donor issues by Worel, Nina, Aljurf, Mahmoud, Anthias, Chloe, Buser, Andreas S, Cody, Meghann, Fechter, Mirjam, Galeano, Sebastian, Greinix, Hildegard T, Kisch, Annika M, Koh, Mickey B C, Mengling, Thilo, Nicoloso, Grazia, Niederwieser, Dietger, Pulsipher, Michael A, Seber, Adriana, Shaw, Bronwen E, Stefanski, Heather E, Switzer, Galen E, Szer, Jeff, van Walraven, Suzanna M, Yang, Hung, Halter, Jörg P

“…The contribution of related donors to the globally rising number of allogeneic haematopoietic stem cell transplantations (HSCT) remains increasingly important,…”
Get full text

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: V. The 2014 Ancillary Therapy and Supportive Care Working Group Report by Carpenter, Paul A, Kitko, Carrie L, Elad, Sharon, Flowers, Mary E.D, Gea-Banacloche, Juan C, Halter, Jörg P, Hoodin, Flora, Johnston, Laura, Lawitschka, Anita, McDonald, George B, Opipari, Anthony W, Savani, Bipin N, Schultz, Kirk R, Smith, Sean R, Syrjala, Karen L, Treister, Nathaniel, Vogelsang, Georgia B, Williams, Kirsten M, Pavletic, Steven Z, Martin, Paul J, Lee, Stephanie J, Couriel, Daniel R

“…Abstract The 2006 National Institutes of Health (NIH) Consensus paper presented recommendations by the Ancillary Therapy and Supportive Care Working Group to…”
Get full text

ROCKin' cGVHD treatment: has the time come? by Halter, Jörg P.

Get full text

Kidney Pathology after Hematologic Cell Transplantation—A Single-Center Observation Study of Indication Biopsies and Autopsies by Girsberger, Michael, Halter, Jörg P., Hopfer, Helmut, Dickenmann, Michael, Menter, Thomas

“…•We studied 17 kidney biopsy specimens and 137 autopsy kidneys from hematopoietic cell transplantation recipients.•Membranous glomerulonephritis was identified…”
Get full text

Low Incidence of hepatic sinusoidal obstruction syndrome/veno-occlusive disease in adults undergoing allogenic stem cell transplantation with prophylactic ursodiol and low-dose heparin by Stutz, Lina, Halter, Jörg P., Heim, Dominik, Passweg, Jakob R., Medinger, Michael

“…Hepatic sinusoidal obstruction syndrome (SOS)/veno-occlusive disease (VOD) is a complication after allogenic hematopoietic stem-cell transplantation…”
Get full text

Anti-GABAA receptor encephalitis 14 months after allogeneic haematopoietic stem-cell transplant for acute myeloid leukaemia by Rusche, Thilo, Yaldizli, Özgür, Galbusera, Riccardo, Mutke, Matthias, Halter, Jörg P, Lieb, Johanna, Matteazzi, Francesca, Stelmes, Anne, Bittner, Jan, Grzonka, Pascale, Frank, Nicole, Cordier, Dominik, Hench, Jürgen, Frank, Stephan, Hirsch, Hans H, Fischer, Urs, Kuhle, Jens, Sutter, Raoul, Rüegg, Stephan, Fisch, Urs

Get full text

Optimized cyclosporine starting dose may reduce risk of acute GvHD after allogeneic hematopoietic cell transplantation: a single-center cohort study by Héritier, Jérémie, Medinger, Michael, Heim, Dominik, Baldomero, Helen, Arranto, Christian, Halter, Jörg P., Passweg, Jakob R., Kleber, Martina

“…Cyclosporine A (CsA) is commonly used for Graft versus Host Disease (GvHD) prophylaxis at a recommended starting dose of 3 mg/kg/d: Evidence for the effect of…”
Get full text

Routine next generation sequencing of lymphoid malignancies: clinical utility and challenges from a 3-Year practical experience by Pillonel, Vincent, Juskevicius, Darius, Bihl, Michel, Stenner, Frank, Halter, Jörg P., Dirnhofer, Stefan, Tzankov, Alexandar

“…Since 2016, a next-generation sequencing (NGS) panel targeting 68 genes frequently mutated in lymphoid malignancies is an accredited part of routine…”
Get full text

Tear Film Proteomics Reveal Important Differences Between Patients With and Without Ocular GvHD After Allogeneic Hematopoietic Cell Transplantation by Gerber-Hollbach, Nadine, Plattner, Kim, O'Leary, Olivia E, Jenoe, Paul, Moes, Suzette, Drexler, Beatrice, Schoetzau, Andreas, Halter, Jörg P, Goldblum, David

“…To date, no biomarkers for ocular graft versus host disease (GvHD), a frequent complication following allogeneic hematopoietic cell transplantation (HCT),…”
Get full text